It’s time to buy shares of this under-the-radar injectables delivery maker with more than 30% upside potential, according to Jefferies.
Communicating your story to the Street
It’s time to buy shares of this under-the-radar injectables delivery maker with more than 30% upside potential, according to Jefferies.